S.2081 - Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019116th Congress (2019-2020)
|Sponsor:||Sen. Peters, Gary C. [D-MI] (Introduced 07/10/2019)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 07/10/2019 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2081 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (07/10/2019)
Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019
This bill requires manufacturers of covered drugs under Medicare medical services to issue rebates to the Centers for Medicare & Medicaid Services. Rebates are calculated based on the number of units sold and the amount by which the manufacturer price exceeds inflation. The bill's requirements do not apply to drugs that cost less than $100 annually per user in 2020 (and as adjusted for inflation annually thereafter) or to drugs on a specified drug shortage list.
The bill also eliminates cost-sharing for such drugs for beneficiaries whose out-of-pocket costs meet or exceed a specified threshold.